PRLB Proto Labs Inc

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 24, 2015

Proto Labs, Inc.

(Exact name of registrant as specified in its charter)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

On September 24, 2015, Proto Labs, Inc. (the “Company”) issued a press release announcing it reached agreement in principle to acquire select assets and operations of Alphaform AG. This press release is furnished as Exhibit 99.1 hereto pursuant to Item 7.01 of this Current Report on Form 8-K, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18 of the Exchange Act. Furthermore, the information contained in Exhibit 99.1 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX

Exhibit 99.1

FOR IMMEDIATE RELEASE

Proto Labs to Acquire Alphaform AG

Acquisition expands Proto Labs’ additive manufacturing presence in Europe

MAPLE PLAIN, MINN.—September 24, 2015—Proto Labs, Inc. (NYSE: PRLB) today announced that it has reached agreement in principle to acquire select assets and operations of Alphaform, AG subject to standard terms and conditions of purchase.

Alphaform is a leading service bureau headquartered in Feldkirchen (Munich), Germany. The planned acquisition will include Alphaform divisions operating in Germany, Finland, and the United Kingdom. This acquisition will significantly expand Proto Labs’ additive manufacturing capabilities in Europe by adding selective laser sintering, direct metal laser sintering and additional stereolithography capabilities. The acquisition also includes the injection molding service currently offered by Alphaform Claho, in Eschenlohe, Germany. MediMet Precision Casting and Implants Technology GmbH, a 100% subsidiary of Alphaform AG is not part of the transaction.

“We are pleased to announce this strategic acquisition which will accelerate the growth of our Additive Manufacturing services in Europe and complement our current Injection Molding and CNC Machining services” said Vicki Holt, President and CEO at Proto Labs. “With those three complementary offerings, we’re uniquely postioned to help designers and engineers take a product from the initial stages of prototyping through low-volume production.”

The transaction is expected to be completed in early October.

About Proto Labs, Inc.

Proto Labs is the world's fastest digital manufacturing source for custom prototypes and low-volume production parts. The technology-enabled company uses advanced 3D printing, CNC machining and injection molding technologies to produce parts within days. The result is an unprecedented speed-to-market value for product designers and engineers worldwide. Visit protolabs.com for more information.

Proto Labs (NYSE:PRLB)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Proto Labs (NYSE:PRLB)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024